Protalix BioTherapeutics
PLX
$1.15
Share price
-2.54%
Change (1 day)
-56.93%
Change (1 year)
Categories
Protalix BioTherapeutics (PLX) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $50.86 M
According to Protalix BioTherapeutics 's latest financial reports the company's total liabilities are $50.86 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Protalix BioTherapeutics - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $50.86 M | -23.43% |
| 2022-12-31 | $66.42 M | -16.65% |
| 2021-12-31 | $79.7 M | -16.08% |
| 2020-12-31 | $94.97 M | -17.93% |
| 2019-12-31 | $0.11 B | 1.49% |
| 2018-12-31 | $0.11 B | 12.14% |
| 2017-12-31 | $0.10 B | 10.27% |
| 2016-12-31 | $92.2 M | 6.74% |
| 2015-12-31 | $86.38 M | -35.52% |
| 2014-12-31 | $0.13 B | -4.51% |
| 2013-12-31 | $0.14 B | 70.9% |
| 2012-12-31 | $82.08 M | 5.4% |
| 2011-12-31 | $77.88 M | 2.41% |
| 2010-12-31 | $76.05 M | -8.14% |
| 2009-12-31 | $82.78 M | 1180.75% |
| 2008-12-31 | $6.46 M | 45.19% |
| 2007-12-31 | $4.45 M | 64.64% |
| 2006-12-31 | $2.7 M | 139.29% |
| 2005-12-31 | $1.13 M | 1491.55% |
| 2004-12-31 | $0.07 M | -9.92% |
| 2003-12-31 | $0.07 M | -0.32% |
| 2002-12-31 | $0.07 M | 2.33% |
| 2001-12-31 | $0.07 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $137.21 B | 269,659.17% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | $1.01 B | 1,904.13% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $0.61 B | 1,114.40% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $35.35 B | 69,403.59% | 🇮🇱 Israel |